GM10272
LCL from B-Lymphocyte
Description:
ANIRIDIA 1; AN1
TRANSLOCATED CHROMOSOME
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases
Chromosome Abnormalities |
| Class |
Ophthalmologic Disorders |
|
Biopsy Source
|
Peripheral vein
|
|
Cell Type
|
B-Lymphocyte
|
|
Tissue Type
|
Blood
|
|
Transformant
|
Epstein-Barr Virus
|
|
Sample Source
|
LCL from B-Lymphocyte
|
|
Race
|
White
|
|
Family Member
|
2
|
|
Relation to Proband
|
half-brother
|
|
Confirmation
|
Clinical summary/Case history
|
|
ISCN
|
46,XY,t(11;22)(11qter>11p13::22q11.2 or 12.2>22qter;22pter>22q11.2 or 12.2:: 11p13>11pter)pat
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis and by Chromosome Analysis |
| |
| Cytogenetics |
Chromosome 11: TRANSLOCATION Breakpoint 11p13 t(11;22)11p13 |
|
Chromosome 22: TRANSLOCATION Breakpoint 22q11 t(11;22)22q11 |
|
Chromosome 22: TRANSLOCATION Breakpoint 22q12 t(11;22)22q12 |
| Remarks |
Clinically affected; aniridia, cataracts, hyperopia, and nystagmus first noted at 3 months of age; at age 12 years there was pendular nystagmus, bilateral total aniridia, bilateral posterior subcapsular cataractous changes, and absent foveae; normal ocular pressure; visual acuity 20/400 corrected; no genitourinary tract abnormalities; IQ=67; familial chromosome translocation; father (GM10274), paternal half-sister (GM10273), and paternal grandmother also affected with aniridia and familial chromosome translocation; seven family members in 4 generations affected with aniridia but karyotype unknown. |
| Moore JW, Hyman S, Antonarakis SE, Mules EH, Thomas GH, Familial isolated aniridia associated with a translocation involving chromosomes 11 and 22 [t(11;22)(p13;q12.2)]. Hum Genet72:297-302 1986 |
| PubMed ID: 3754537 |
| Split Ratio |
1:2 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
| Serum |
20% fetal bovine serum Not Inactivated |
| Substrate |
None specified |
| Subcultivation Method |
dilution - add fresh medium |
| Supplement |
- |
|
|